Nuvation Bio Inc (NUVB) Stock: A Year of Market Fluctuations

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Nuvation Bio Inc’s current trading price is -31.98% away from its 52-week high, while its distance from the 52-week low is 52.60%. The stock’s price range for this period has been between $1.54 and $3.45 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.64 million for the day, a number notably lower than the average daily volume of 5.99 million over the last three months.

Nuvation Bio Inc (NUVB) stock is currently valued at $2.35. During the last session, the stock experienced a remarkable rise, reaching $10.0 after opening at $2.35. The stock briefly dropped to $5.0 before ultimately closing at $2.37.

Nuvation Bio Inc’s market performance has been unstable in recent times.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Nuvation Bio Inc (NUVB) has experienced a quarterly rise of 12.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 799.61M and boasts a workforce of 220 employees.

Nuvation Bio Inc: What Analysts Are Saying

As of right now, 4 analysts are rating Nuvation Bio Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.12, with a change in price of +0.14. Similarly, Nuvation Bio Inc recorded 4,899,595 in trading volume during the last 100 days, posting a change of +6.33%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NUVB stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.

NUVB Stock Stochastic Average

As of today, Nuvation Bio Inc’s raw stochastic average for the last 50 days stands at 65.55%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 41.43%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 41.28% and 38.37%, respectively.

NUVB Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -30.06%. However, over the last six months, the performance has been stronger by -2.49%. The price of NUVB increased 14.63% over the last 30 days. And in the last five days, it has fallen by -2.49%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.